✦ LIBER ✦

Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study

✍ Scribed by Jean-Luc Raoul; Jean-Luc Van Laethem; Marc Peeters; Catherine Brezault; Fares Husseini; Laurent Cals; Johannes Nippgen; Anja-Helena Loos; Philippe Rougier

Book ID: 115011526
Publisher: BioMed Central
Year: 2009
Tongue: English
Weight: 890 KB
Volume: 9
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-9-112

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

664 PUBLICATION Cetuximab in combination

664 PUBLICATION Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Use of the folinic acid/5-fluorouracil/i

Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study

✍ Eric François; Jean-François Berdah; Emmanuel Chamorey; Gérard Lesbats; Eric Tei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 286 KB

FOLFOXIRI (folinic acid, 5-fluorouracil,

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)

✍ Souglakos, J; Androulakis, N; Syrigos, K; Polyzos, A; Ziras, N; Athanasiadis, A; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 128 KB

Safety and efficacy of second-line treat

Safety and efficacy of second-line treatment with folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in combination of panitumumab and bevacizumab for patients with metastatic colorectal cancer

✍ Xie, Song; Han, Guoping; Fan, Zhikun; He, Lifeng; Xu, Wenbing; Qin, Zhen 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 253 KB

Phase I/II study of first-line irinoteca

Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer

✍ Thomas Kuehr; Paul Ruff; Bernardo L Rapoport; Stephen Falk; Francis Daniel; Conr 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 304 KB

A phase II study of irinotecan plus chro

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

✍ Garufi, C; Bria, E; Vanni, B; Zappalà, A M R; Sperduti, I; Terzoli, E 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB